🖼
FIGURE 4 — Icariin modulates osteogenic and adipogenic differentiation in ADSCs via the Hip
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-23402e4f-47bc-4793-ad72-fa8ce1
FIGURE 4Figure 4
Tracing Detection of Lentiviral Infection of EGFP-ADSCs In Vivo in Rats. Rats were divided into six groups: control, resveratrol (100 μmol/L), and ICA (1, 10, 50, 100 μmol/L). Labeled ADSCs were injected subcutaneously, and tissue samples were collected at 10, 14, and 21 days post-injection for immunofluorescence analysis. (A) Immunofluorescent detection of EGFP-ADSCs in subcutaneous adipose tissue of rats (Microscope ×100, Scale = 200 μm). (B) Quantitative analysis of fluorescence intensity at different time points and in different groups of EGFP-ADSCs in subcutaneous adipose tissue of rats. The data were obtained from multiple analyses (n = 3). Statistical significance is indicated by: * p < 0.05, ** p < 0.01 vs. the control group; # p < 0.05, ## p < 0.01 vs. the RES group.
▸Metadata
| pmid | 23402e4f-47bc-4793-ad72-fa8ce1bf1f80 |
| caption | Tracing Detection of Lentiviral Infection of EGFP-ADSCs In Vivo in Rats. Rats were divided into six groups: control, resveratrol (100 μmol/L), and ICA (1, 10, 50, 100 μmol/L). Labeled ADSCs were inj |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC11770256/bin/fphar-15-1510561-g004.jpg |
| paper_title | Icariin modulates osteogenic and adipogenic differentiation in ADSCs via the Hippo-YAP/TAZ pathway: a novel therapeutic strategy for osteoporosis. |
| figure_label | FIGURE 4 |
| figure_number | 4 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.